medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2009, Number 02

<< Back Next >>

Ginecol Obstet Mex 2009; 77 (02)

Utility of the determination of the foetal fibronectina in pregnancies of 40 weeks or more to predict the beginning of labor

García GM, Rodríguez LR, Gutiérrez CM, Fernández RM, Casas GA, Padilla GB

Language: Spanish
References: 10
Page: 89-95
PDF size: 53.41 Kb.


ABSTRACT

Background: Perinatal morbidity and mortality increase in proportion to the time from waited date of labor to birth. A test helping to predict pregnancies is required, which also helps to predict pregnancies that will progress more than 41 weeks.
Objective: To determine the usefulness of fetal fibronectin in vaginal secretions to predict pregnancies that will progress 41 weeks or more.
Material and methods: A cohort and descriptive study was done in which 144 women with a pregnancy of 40 weeks or more were included. Fetal fibronectin was detected in cervix-vaginal secretions and time from the sample obtaining to birth was estimated.
Results: Seventy patients with positive fibronectin were recorded; 92% had labor in the following seven days from the sample obtaining (interval mean: 3.1 days). The remaining patients (n = 44) resulted with negative fibronectin; only 37.5% had spontaneous labor, but none of them during the first four days from the sample obtaining (mean: 7.9 days).
Conclusion: Absence of fetal fibronectin in vaginal secretions is a good prognostic marker to identify patients who will achieve a pregnancy of 41 weeks or more (sensitivity of 70% and specificity of 84%; positive and negative predictive value of 75% and 80.7%, respectively, and relative risk of 10, CI 95%, 5.7-14.3). This method is useful to prevent perinatal complications inherent to the pregnancy of 41 weeks or more.


REFERENCES

  1. Norwitz ER, Snegovkikh VV, Cauguey AB. Prolonged pregnancy: when should we intervene? Clin Obst Gynecol 2007;50(2):547-57.

  2. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. A Clinical Trial of Induction of Labor Versus Expectant Management in Postterm Pregnancy. Am J Obstet Gynecol 1994;170(3):716-23.

  3. Sennstrom MB, Granstrom LM, Lockwood CJ, Omazic B. Cervical fetal fibronectin correlates to prostaglandin E2-induced cervical ripening and can be identified in cervical tissue. Am J Obstet Gynecol 1998;178(3):540-5.

  4. Rozenberg P, Goffinet F, Hessabi M. Comparison of the Bishop score, ultrasonographically measured cervical length, and fetal fibronectin assay in predicting time until delivery and type at term. Am J Obstet Gynecol 2000;182(1 Pt 1):108-13.

  5. Blanch G, Olah SJ, Walkinshaw S. The presence of fetal fibronectin in the cervicovaginal secretions of women at term-Its role in the assessment of women before labor induction and in the investigation of the physiologic mechanism of labor. Am J Obstet Gyneco l996;174(1):262-6.

  6. Lockwood CJ, Moscarelli RD, Wein R, Lynch L, et al. Low concentrations of vaginal fetal fibronectin as a predictor of deliveries ocurring after 41 weeks. Am J Obstet Gynecol 1994;171(1):1-4.

  7. Ahner R, Kiss H, Egarter C, Zeillinger R, et al. Fetal fibronectin as a marker to predict the onset of term labor and deliver. Am J Ostet and Gynecol 1995;172(1):134-7.

  8. Ahner R, Kub-Csizi P, Heinzl H, Bikas D, et al. The fast-reacting fetal fibronectin test: A screening method for better prediction of the time of delivery. Am J Obstet Gynecol 1997;177(6):1478-82.

  9. Caughey AB, Stotolan NE, Washington AE, Escobar GJ. Maternal and obstetric complications of pregnancy are associated with increasing gestational age at term. Am J Obstet Gynecol 2007;196(2):155e1-155e6.

  10. Karchmer KS, Fernández Del Castillo SC. Obstetricia y medicina perinatal. Temas selectos. México: COMEGO, 2006;pp:157.




2020     |     www.medigraphic.com